IRIS
TORNIAI, MARIANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.680
EU - Europa 940
AS - Asia 876
SA - Sud America 143
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 68
OC - Oceania 1
Totale 4.787
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.618
SG - Singapore 306
IT - Italia 186
CN - Cina 165
VN - Vietnam 157
RU - Federazione Russa 155
BR - Brasile 113
DE - Germania 100
UA - Ucraina 91
IE - Irlanda 80
SE - Svezia 76
HK - Hong Kong 65
FI - Finlandia 64
FR - Francia 53
TR - Turchia 52
CI - Costa d'Avorio 42
GB - Regno Unito 41
BD - Bangladesh 35
CA - Canada 34
IN - India 29
DK - Danimarca 26
KR - Corea 16
BE - Belgio 15
MA - Marocco 15
PL - Polonia 14
AR - Argentina 13
JP - Giappone 12
NL - Olanda 12
ZA - Sudafrica 11
ES - Italia 9
IQ - Iraq 6
MX - Messico 6
LT - Lituania 5
SV - El Salvador 5
CO - Colombia 4
EC - Ecuador 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
CR - Costa Rica 3
GP - Guadalupe 3
HN - Honduras 3
ID - Indonesia 3
KE - Kenya 3
PH - Filippine 3
PK - Pakistan 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
SA - Arabia Saudita 2
SN - Senegal 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DZ - Algeria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MN - Mongolia 1
NG - Nigeria 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TG - Togo 1
TL - Timor Orientale 1
TN - Tunisia 1
VE - Venezuela 1
Totale 4.720
Salva come PNG Salva come JPEG
Città #
Ashburn 479
Singapore 225
Chandler 218
Fairfield 139
Jacksonville 132
Des Moines 113
San Jose 105
New York 88
Dublin 80
Council Bluffs 76
Wilmington 74
Boardman 68
Hong Kong 64
Woodbridge 58
Seattle 57
Los Angeles 56
Houston 54
Ho Chi Minh City 50
Beijing 49
Cambridge 49
Dallas 47
Abidjan 42
The Dalles 38
Ann Arbor 37
Munich 36
Princeton 35
Hanoi 33
Turku 32
Lawrence 31
Turin 31
San Mateo 30
Lauterbourg 28
Moscow 28
Santa Clara 20
Orem 19
Helsinki 18
Milan 17
Washington 16
Chicago 15
Phoenix 15
Brussels 14
Buffalo 14
San Diego 14
Warsaw 14
Irving 13
Montreal 13
São Paulo 13
Chennai 12
Frankfurt am Main 12
Rome 11
Centro 10
Columbus 10
Hefei 10
London 10
Tokyo 10
Da Nang 9
Falls Church 9
Haiphong 9
Pune 9
Atlanta 8
Brooklyn 8
Shanghai 8
Hải Dương 7
Johannesburg 7
Norwalk 7
Amsterdam 6
Ancona 6
Denver 6
Guangzhou 6
Kilburn 6
Miano 6
Poplar 6
Ankara 5
Paris 5
Pittsburgh 5
Salt Lake City 5
San Salvador 5
Guarulhos 4
Istanbul 4
Manchester 4
Rio de Janeiro 4
Urbisaglia 4
Baghdad 3
Baku 3
Charlotte 3
City of London 3
Cleveland 3
Edison 3
Jiaxing 3
Montegiorgio 3
Mumbai 3
Nairobi 3
North Bergen 3
Quito 3
Salvador 3
Vancouver 3
Wuxi 3
Điện Bàn 3
Ấp Tháp Mười 3
Anápolis 2
Totale 3.203
Salva come PNG Salva come JPEG
Nome #
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 263
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 223
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 173
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 172
Gender Differences and Outcomes in Melanoma Patients 170
Electrolyte disorders in cancer patients: a systematic review 170
Benefits and limitations of a multidisciplinary approach in cancer patient management 166
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 159
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 159
High CTLA-4 expression correlates with poor prognosis in thymoma patients 159
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 154
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 154
Systemic treatment for lung carcinoids: from bench to bedside 153
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 152
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 152
Gender differences and outcome of melanoma patients 150
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 150
Hyponatremia in cancer patients: Time for a new approach 149
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 149
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 143
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 142
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 140
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 135
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis 134
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 130
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 129
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? 126
Medical Treatment in Gastroenteropancreatic Neuroendocrine Neoplasms: a look into the future. 123
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 122
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study 117
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 106
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) 63
Totale 4.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.168
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022180 0 0 0 3 7 30 11 12 28 24 25 40
2022/2023666 40 78 42 58 30 165 0 35 128 4 70 16
2023/2024360 51 6 31 22 48 107 7 25 1 15 1 46
2024/2025589 71 53 17 4 41 31 52 25 103 27 78 87
2025/20261.687 153 77 54 190 206 131 300 158 127 165 47 79
2026/2027386 71 113 66 136 0 0 0 0 0 0 0 0
Totale 4.787